Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 63,400 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
View Top Employees from Novo NordiskWebsite | https://www.novonordisk.com |
Ticker | NVO |
Revenue | $21 billion |
Employees | 56,641 (49,882 on RocketReach) |
Founded | 1923 |
Address | 1 Novo Allé, Bagsvaerd, Capital Region 2880, DK |
Phone | (454) 444-8888 |
Fax | (454) 449-0555 |
Technologies |
JavaScript,
HTML,
Twitter
+439 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Healthcare, Insulin, Growth Hormone, Immunotherapy |
Keywords | Diabetes Treatment, Biopharmaceuticals, Global Healthcare, Blood Disorders Treatment, Scientific Advancement, Healthcare Solution, Pharmaceutical Companies |
Competitors | Baxter International Inc., Bristol Meyers Squibb, Emcure Pharmaceuticals Limited, Genentech, sanofi |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 44 Companies, NAICS Code 621 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies |
Looking for a particular Novo Nordisk employee's phone or email?
The Novo Nordisk annual revenue was $21 billion in 2024.
Anna Frable is the Vice President, US Communications of Novo Nordisk.
49,882 people are employed at Novo Nordisk.
Novo Nordisk is based in Bagsvaerd, Capital Region.
The NAICS codes for Novo Nordisk are [44, 621, 6215, 62, 62151].
The SIC codes for Novo Nordisk are [28, 283].